期刊文献+

奥洛他定滴眼液和依美斯汀滴眼液治疗过敏性结膜炎的疗效比较 被引量:9

下载PDF
导出
摘要 目的研究比较0.1%盐酸奥洛他定滴眼液和0.05%富马酸依美斯汀滴眼液治疗过敏性结膜炎的疗效。方法应用奥洛他定滴眼液和富马酸依美斯汀滴眼液分别治疗两组过敏性结膜炎患者,连续治疗2周。于治疗前、治疗后第三天、第七天及第十四天随访观察各指标。结果治疗早期,奥洛他定治疗起效快,患者症状改善较依美斯汀组明显,差异有统计学意义。而治疗后14d,两组疗效差异无统计学意义。结论在过敏性结膜炎早期如能给予奥洛他定滴眼液治疗,将能更好的缓解患者的症状,改善生活质量。
作者 陈轶
出处 《海峡药学》 2013年第12期155-157,共3页 Strait Pharmaceutical Journal
  • 相关文献

参考文献10

  • 1Abelson MB,George MA,Garofalo C. Differential diagnosis of ocular allergic disorders[J].{H}ANNALS OF ALLERGY,1993.95-109.
  • 2Berdy GJ,Hedqvist B. Ocular allergic disorders and dry eye disease:associations,diagnostic dilemmas,and management[J].{H}Acta Ophthalmologica Scandinavica Supplement,2000,(230):32-37.
  • 3刘祖国,肖启国.过敏性结膜炎的诊治[J].中华眼科杂志,2004,40(7):500-502. 被引量:63
  • 4Woodward DF,Hawley SB,Williams LS. Studies on the ocular pharmacology of prostaglandin D2[J].{H}Investigative Ophthalmology & Visual Science,1990.138-146.
  • 5Katelaris CH. Ocular allergy:implications for the clinical immunologist[J].{H}Annals of Allergy Asthma and Immunology,2003.23-27.
  • 6Bielory L. Allergic and immunologic disorders of the eye.Part I:immunology of the eye[J].{H}Journal of Allergy and Clinical Immunology,2000.805-816.
  • 7Verin P,Easty DL,Secchi A. Clinical evaluation of twice-daily emedastine 0.05% eye drops (Emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis[J].{H}American Journal of Ophthalmology,2001.691-698.
  • 8Yanni JM,Stephens DJ,Parnell DW. Preclinical efficacy of emedastine,a potent,selective histamine H1 antagonist for topical ocular use[J].{H}Journal of Ocular Pharmacology,1994.665-675.
  • 9Eiichi Uchio. Treatment of allergic conjunctivitis with olopatadine hydrochloride eye drops[J].Clin Ophthalmol,2008.525-531.
  • 10Mah FS,O′Brien T,Kim T. Evaluation of the effects of olopatadine ophthalmic solution,0.2% on the ocular surface of patients with allergic conjunctivitis and dry eye[J].{H}CURRENT MEDICAL RESEARCH AND OPINION,2008.441-447.

二级参考文献15

  • 1Keane-Myers A. The pathogenesis of allergic conjunctivitis. Curr Allergy Asthma Rep, 2001,1:550-557.
  • 2McGill JI, Holgate ST, Church MK, et al. Allergic eye disease mechanisms. Br J Ophthalmol ,1998,82:1203-1214.
  • 3Stahl JL, Cook EB, Barney NP, et al. Pathophysiology of ocular allergy: the roles of conjunctival mast cells and epithelial cells. Curr Allergy Asthma Rep, 2002,2:332-339.
  • 4Leonardi A. Role of histamine in allergic conjunctivitis. Acta Ophthalmol Scand Suppl,2000,230:18-21.
  • 5Hannouche D, Hoang-Xuan T. Allergic conjunctivitis. In: Hoang-Xuan T, Baudouin C, Creazot-Garcher C, eds. Inflammatory diseases of the conjunctiva. New York: Stettgart, 2001.53-66.
  • 6Calonge M. Classification of ocular atopic/allergic disorders and conditions: an unsolved problem. Acta Ophthalmol Scand Suppl, 1999,228:10-13 .
  • 7Dinowitz M, Rescigno R, Bielory L. Ocular allergic diseases: differential diagnosis, examination techniques, and testing. Clin Allergy Immunol, 2000,15:127-150.
  • 8Belfort G, Marbeck P, Hsu CC, et al. Epidemiological study of 134 subjects with allergic conjunctivitis. Acta Ophthalmol Scand Suppl, 2000,230:38-40.
  • 9Katelaris CH. Giant papillary conjunctivitis-a review. Acta Ophthalmol Scand Suppl, 1999, 228:17-20.
  • 10Leonardi A, Secchi AG. Vernal keratoconjunctivitis. Int Ophthalmol Clin, 2003 ,43:41-58.

共引文献62

同被引文献60

引证文献9

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部